SCHEMBL16178154

SCHEMBL16178154

COc1ccc(CN(c2nccs2)S(=O)(=O)c2ccc(F)c(F)c2)c(OC)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX12 P18054 1/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
BMP1 P13497 2/20 0.38
TAS2R14 Q9NYV8 2/20 0.38
TP53 P04637 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
SCN1A P35498 1/20 0.36
SCN2A Q99250 1/20 0.36
SCN3A Q9NY46 1/20 0.36
GAA P10253 2/20 0.36
TSHR P16473 1/20 0.36
POLB P06746 1/20 0.36
KDM4E B2RXH2 1/20 0.35
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
APH1B Q8WW43 1/20 0.35
NCSTN Q92542 1/20 0.35
APH1A Q96BI3 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16757195 0.92 SOS1 (0.38) ALOX12MEN1KMT2ATAS2R14TP53
SCHEMBL29668838 0.90 KEAP1 (0.41) ALOX12MEN1KMT2ATAS2R14TP53
SCHEMBL17048628 0.90 KEAP1 (0.41) ALOX12MEN1KMT2ATAS2R14TP53
SCHEMBL16771674 0.90 GAA (0.41) ALOX12MEN1KMT2ATAS2R14TP53
SCHEMBL322898 0.89 SLC22A12 (0.42) ALOX12MEN1KMT2ASCN9A
SCHEMBL3123476 0.89 MEN1 (0.41) ALOX12MEN1KMT2ATAS2R14NPC1
SCHEMBL29669070 0.88 MEN1 (0.40) ALOX12MEN1KMT2ATP53SCN1A
SCHEMBL15466024 0.88 MEN1 (0.40) ALOX12MEN1KMT2ATP53SCN1A
SCHEMBL20485792 0.87 CNR2 (0.43) ALOX12MEN1KMT2ATP53GAA
SCHEMBL29668807 0.86 KDM4E (0.42) ALOX12MEN1KMT2ATP53SCN1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014170793-A1 SULFONAMIDES FOR THE TREATMENT OF GOUT PFIZER LIMITED (GB) 2014-10-23 WO disclosed
US-20140315933-A1 CHEMICAL COMPOUNDS PFIZER LIMITED (GB) 2014-10-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140315933-A1 CHEMICAL COMPOUNDS SULT2A1, SULT1A1, SULT1E1 ALOX12 4209/4885MEN1 3205/4885KMT2A 1586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.